Thrombosis and Hemostasis

Thrombosis, the formation of a blood clot inside a blood vessel that obstructs the flow of blood through the circulatory system, is thought to occur when natural hemostatic mechanisms, which help restrict the clot to the site of injury, are genetically impaired or are overwhelmed by the severity of the initial injury. Discover the latest research on hemostasis and thrombosis here.

December 7, 2021
Open Access

Azolo[1,5-a]pyrimidines and Their Condensed Analogs with Anticoagulant Activity
Konstantin V. SavateevGeorgiy M. Uskov
December 7, 2021

[Carotid endarterectomy in patients with internal carotid artery thrombosis in the acutest period of ischemic stroke with COVID-19].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
A N KazantsevYu P Linets
December 7, 2021

Medical Adjuvant Therapy in Reducing Thrombosis With Arteriovenous Grafts and Fistulae Use: A Meta-Analysis of Randomized Controlled Trials.

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Kaleem UllahIvan Cherrez-Ojeda
December 7, 2021

Strategies in Synthesis of Heparin/Heparan Sulfate Oligosaccharides: 2000-Present.

Advances in Carbohydrate Chemistry and Biochemistry
Steven B Dulaney, Xuefei Huang
December 6, 2021

Comparison of 4F-PCC in obese and nonobese patients with life-threatening bleeding or requiring emergent surgery.

Research and Practice in Thrombosis and Haemostasis
Jessica RimsansLaurel Omert
December 6, 2021

[Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association
December 6, 2021

Utilization of apixaban anti-Xa levels in transition from apixaban to warfarin in a patient with chronic renal dysfunction.

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Brittany Elgersma, Sara Zochert
December 4, 2021

[Features of pathological anatomy of COVID-19 according to autopsy results in the Volgograd Region].

Arkhiv patologii
A V SmirnovD Yu Gurov
December 5, 2021

Coagulation Abnormalities and Clinical Complications in Children With SARS-CoV-2: A Systematic Review of 48,322 Patients.

Journal of Pediatric Hematology/oncology
Charles Griffin McDanielElisabeth T Tracy
December 5, 2021

Patient education program at the forefront of cancer-associated thrombosis care.

Journal De Médecine Vasculaire
M SebuhyanD Farge
December 4, 2021

Non-synonymous alterations in AKR7A3 and ABCA6 correlate with bleeding in aged patients treated with rivaroxaban.

Clinical and Translational Science
Ming ZhaoLiping Yang
December 4, 2021

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19.

Blood Advances
Malgorzata WygreckaKlaus T Preissner
December 4, 2021
Open Access

Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target.

Frontiers in Cell and Developmental Biology
Shaoshan Mai, Iwona Inkielewicz-Stepniak

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2021 Meta ULC. All rights reserved